Clinical Trial: Glucosamine Sulphate and Ginkgo Biloba as Antifungal Activity for Treating Tinea Pedis

Study Status: Recruiting
Recruit Status: Recruiting
Study Type: Interventional

Official Title: Glucosamine Sulphate and Ginkgo Biloba for Treating Tinea Pedis

Brief Summary: Tinea Pedis infected the feet of about 20-25% of the world population. Tinea Pedis is a fungal infection of the feet and it is easily spread. Oral therapy is usually used for chronic conditions or when topical treatment has failed. The aim of this study is to prove the antifungal and antibacterial activity of Ginko Biloba (GKB) & Glucosamine (GL) as separate material or both in combination.

Detailed Summary: Ginko Biloba (GKB) & Glucosamine (GL) were formulated in different dosage forms such as capsules, hydrogel and spray. GKB&GL were in filled in hard gelatin capsules as three formulae (GKB caps, GL caps and both as mixture in caps). Also, GKB&GL were formulated in hydrogel using 2% carbopol 934 as three formulae (GKB only, GL only and both as mixture). The same also were formulated as spray using alcohol, water and glycerol in concentration of 60%, 20% and 20% respectively. The study included 5 trials, involving 35 participants. The oral formulae were tried on 30 participants having Tenia Pedis. Fluconazole was as standard antifungal drug.The antifungal activity of all gel formulae was determined by Agar well-diffusion method. It is also important to follow up and collect data, preferably for six months for local and systemic activity, to establish whether or not the infection recurred or not. In future clinical trials, research should consider the costs of the different treatment approaches.
Sponsor: Ahmed A. H. Abdellatif

Current Primary Outcome: Assessment the antifungal activity of Ginkgo Biloba & Glucosamine [ Time Frame: six months ]

Ginkgo Biloba and Glucosamine will be applied with infected patients even systemically or topically. The results will be compared with control groups to prove the Antifungal Activity.


Original Primary Outcome: Same as current

Current Secondary Outcome: Stability test for different dosage forms [ Time Frame: three months ]

Stability test will be studied for dosage forms. The test will carried out by standing the products on shelf life for three months. The stability test will be recorded using high performance liquid chromatography each thee days.


Original Secondary Outcome: Same as current

Information By: Al-Azhar University

Dates:
Date Received: November 26, 2015
Date Started: January 2016
Date Completion: October 2017
Last Updated: August 26, 2016
Last Verified: August 2016